Breaking News Instant updates and real-time market news.

EXEL

Exelixis

$16.32

-0.24 (-1.45%)

15:55
12/22/16
12/22
15:55
12/22/16
15:55

Exelixis put volume heavy and directionally bearish

Bearish flow noted in Exelixis with 4,492 puts trading, or 6x expected. Most active are Jan-17 16 puts and Jan-17 15 puts, with total volume in those strikes near 3,100 contracts. The Put/Call Ratio is 1.66, while ATM IV is up over 12 points on the day. Earnings are expected on February 28th.

  • 19

    Jan

EXEL Exelixis
$16.32

-0.24 (-1.45%)

11/03/16
DBAB
11/03/16
INITIATION
Target $17
DBAB
Buy
Exelixis initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Andrew Peters started Exelixis with a Buy rating and $17 price target. He calls the stock his top pick in mid-cap biotech and sees "meaningful upside" from current levels.
11/03/16
11/03/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BioMarin (BMRN) initiated with a Buy at Deutsche Bank. 2. Ambev (ABEV) reinstated with an Equal Weight at Barclays. 3. ARIAD (ARIA) initiated with a Hold at Deutsche Bank. 4. Thomson Reuters (TRI) reinstated with a Neutral at JPMorgan. 5. Exelixis (EXEL) initiated with a Buy at Deutsche Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage click here.
11/14/16
PIPR
11/14/16
NO CHANGE
PIPR
Piper sees Biotech rally continuing into 2017, lays out five to own
Piper Jaffray analyst Edward Tenthoff expects the rally in Biotechs, following "the trifecta" of a Trump Presidential election, Republican Congress sweep and defeat of Prop 61 in California, to continue into 2017. He recommends focusing on shares of Vertex (VRTX), Regeneron (REGN), Alnylam (ALNY), Exelixis (EXEL) and OncoMed (OMED). Tenthoff has a Neutral rating on Regeneron and Overweight ratings on the other four names.
12/21/16
PIPR
12/21/16
NO CHANGE
PIPR
Piper lays out top BioPharma picks for 2017
Piper Jaffray analysts laid out their top BioPharma picks for 2017. Analyst Richard Purkiss favors Pfizer (PFE) and Eli Lilly (LLY) as his top large pharma picks. Analyst Joshua Schimmer calls Gilead (GILD) and Alexion (ALXN) his top large cap picks. Analyst David Amsellem names Horizon Pharma (HZNP) his top specialty pharma pick. Piper's other top Biopharma picks for 2017 include ACADIA (ACAD), Aimmune (AIMT), Akorn (AKRX), Alnylam (ALNY), Axovant Sciences (AXON), Cara Therapeutics (CARA), CoLucid Pharmaceuticals (CLCD), Eale Pharmaceuticals (EGRX), Exelixis (EXEL), Ionis Pharmaceuticals (IONS), Mallinckrodt (MNK), Neurocrine (NBIX), Nektar (NKTR), Otonomy (OTIC), Reata Pharmaceuticals (RETA), Rigel Pharmaceuticals (RIGL), Ignyta (RXDX), Theravance Biopharma (TBPH), Versartis (VSAR) and Voyager Therapeutics (VYGR). The analysts look for recent momentum in BioPharma to continue in 2017. They believe innovation and potentially repatriation should lead to increased merger activity.

TODAY'S FREE FLY STORIES

USO

United States Oil Fund

$11.35

0.28 (2.53%)

06:48
11/20/17
11/20
06:48
11/20/17
06:48
Technical Analysis
United States Oil Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$35.00

0.7 (2.04%)

06:47
11/20/17
11/20
06:47
11/20/17
06:47
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$24.56

-1.07 (-4.17%)

06:47
11/20/17
11/20
06:47
11/20/17
06:47
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WCG

WellCare

$198.00

-2.02 (-1.01%)

06:47
11/20/17
11/20
06:47
11/20/17
06:47
Recommendations
WellCare analyst commentary  »

WellCare price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$10.36

0.37 (3.70%)

06:47
11/20/17
11/20
06:47
11/20/17
06:47
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$39.83

0.57 (1.45%)

06:46
11/20/17
11/20
06:46
11/20/17
06:46
Technical Analysis
MSCI Brazil Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYY

WidePoint

$0.58

0.0289 (5.27%)

06:46
11/20/17
11/20
06:46
11/20/17
06:46
Hot Stocks
WidePoint awarded $4.4M task order by USCIS »

WidePoint announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

EFA

iShares MSCI EAFE Index Fund

$68.91

-0.25 (-0.36%)

06:46
11/20/17
11/20
06:46
11/20/17
06:46
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGT

International Game

$28.54

-0.26 (-0.90%)

06:42
11/20/17
11/20
06:42
11/20/17
06:42
Recommendations
International Game analyst commentary  »

International Game price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$34.51

-0.01 (-0.03%)

, TWX

Time Warner

$88.72

0.71 (0.81%)

06:41
11/20/17
11/20
06:41
11/20/17
06:41
Periodicals
AT&T stands behind Jeff Zucker despite Trump's CNN criticism, NY Post reports »

AT&T (T) is…

T

AT&T

$34.51

-0.01 (-0.03%)

TWX

Time Warner

$88.72

0.71 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

INVA

Innoviva

$13.06

0.09 (0.69%)

, GSK

GlaxoSmithKline

$35.06

-0.13 (-0.37%)

06:37
11/20/17
11/20
06:37
11/20/17
06:37
Initiation
Innoviva, GlaxoSmithKline initiated  »

Innoviva initiated with a…

INVA

Innoviva

$13.06

0.09 (0.69%)

GSK

GlaxoSmithKline

$35.06

-0.13 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNK

SPDR Barclays High Yield Bond

$36.79

-0.02 (-0.05%)

06:37
11/20/17
11/20
06:37
11/20/17
06:37
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SJB

ProShares Short High Yield

$23.25

-0.02 (-0.09%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$1.94

0.04 (2.11%)

, COTY

Coty

$17.05

0.2 (1.19%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Recommendations
Avon Products, Coty analyst commentary  »

Coty may consider…

AVP

Avon Products

$1.94

0.04 (2.11%)

COTY

Coty

$17.05

0.2 (1.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGND

Ligand

$140.31

-1.4 (-0.99%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Downgrade
Ligand rating change  »

Ligand downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.47

-0.06 (-0.07%)

06:36
11/20/17
11/20
06:36
11/20/17
06:36
Technical Analysis
iShares iBoxx $ High Yield Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$120.46

0.15 (0.12%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Technical Analysis
iShares iBoxx $ Investment Grade Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLT

iShares 20+ Year Treasury Bond Fund

$126.39

0.93 (0.74%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$24.99

-0.16 (-0.64%)

, BA

Boeing

$262.26

-1.44 (-0.55%)

06:35
11/20/17
11/20
06:35
11/20/17
06:35
Periodicals
Airbus faces challenges over stalled A380 Emirates deal, Reuters reports »

Airbus (EADSY) is facing…

EADSY

Airbus

$24.99

-0.16 (-0.64%)

BA

Boeing

$262.26

-1.44 (-0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Hot Stocks
Altice: Majority investor Next does not hold any margin loan exposure to Altice »

Information service…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLV

iShares Silver Trust

$16.31

0.19 (1.18%)

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Technical Analysis
iShares Silver Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USLV

VelocityShares 3x Long Silver ETN

$12.56

0.45 (3.72%)

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

06:34
11/20/17
11/20
06:34
11/20/17
06:34
Hot Stocks
Breaking Hot Stocks news story on Altice »

Altice says will not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYR

DJ US Real Estate Index Fund

$82.14

-0.38 (-0.46%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATCEY

Altice

, ATUS

Altice USA

$19.86

-0.38 (-1.88%)

06:33
11/20/17
11/20
06:33
11/20/17
06:33
Periodicals
Altice says not in preparation of cash raising by means of equity issuance »

Altice N.V. (ATCEY)…

ATCEY

Altice

ATUS

Altice USA

$19.86

-0.38 (-1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.